ATP-PRT ATP-PRT variant with reduced feedback inhibition by histidine and histidine-producing strain expressing the same

The present invention relates to an E. coli hisG-derived ATP-phosphoribosyltransferase variant having reduced feedback inhibition by histidine and a strain expressing the same. Since the activity can be maintained even at a high histidine concentration, histidine production can increase. In the ATP-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YANG CHEL MIN, JO YOUNG IL, HAN JONG YUN, KIM YONG SOO
Format: Patent
Sprache:eng ; kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to an E. coli hisG-derived ATP-phosphoribosyltransferase variant having reduced feedback inhibition by histidine and a strain expressing the same. Since the activity can be maintained even at a high histidine concentration, histidine production can increase. In the ATP-phosphoribosyltransferase variant, arginine at position 250 is substituted with histidine. 본 발명은 히스티딘에 의한 피드백 억제가 감소된 대장균 hisG 유래 ATP-포스포리보실전이효소의 변이체 및 이를 발현하는 균주에 대한 것으로, 높은 히스티딘 농도에서도 활성을 유지하므로 히스티딘 생산을 증가시킬 수 있다.